Financial results - PROPHARMA PLUS S.R.L.

Financial Summary - Propharma Plus S.r.l.
Unique identification code: 36685983
Registration number: J33/1356/2016
Nace: 4773
Sales - Ron
247.958
Net Profit - Ron
33.929
Employees
4
Open Account
Company Propharma Plus S.r.l. with Fiscal Code 36685983 recorded a turnover of 2020 of 247.958, with a net profit of 33.929 and having an average number of employees of 4. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Propharma Plus S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 16.982 243.466 242.047 223.276 254.991 - - - -
Total Income - EUR - 16.982 243.665 242.197 223.276 256.294 - - - -
Total Expenses - EUR - 12.392 187.229 199.270 187.787 219.166 - - - -
Gross Profit/Loss - EUR - 4.590 56.436 42.927 35.490 37.128 - - - -
Net Profit/Loss - EUR - 4.081 54.001 40.507 33.255 34.892 - - - -
Employees - 0 1 3 3 4 - - - -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 16.4%, from 223.276 euro in the year 2019, to 254.991 euro in 2020. The Net Profit increased by 2.267 euro, from 33.255 euro in 2019, to 34.892 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Propharma Plus S.r.l.

Rating financiar

Financial Rating -
PROPHARMA PLUS S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Propharma Plus S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Propharma Plus S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Propharma Plus S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Propharma Plus S.r.l. - CUI 36685983

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 94 3.325 6.223 3.937 6.386 - - - -
Current Assets - 19.197 79.073 128.781 174.513 170.651 - - - -
Inventories - 13.808 20.694 17.838 16.445 5.603 - - - -
Receivables - 0 44.361 90.743 141.603 147.797 - - - -
Cash - 5.389 14.019 20.200 16.465 17.251 - - - -
Shareholders Funds - 4.125 54.050 93.565 119.742 113.398 - - - -
Social Capital - 45 44 43 44 43 - - - -
Debts - 15.166 28.349 41.440 58.730 63.639 - - - -
Income in Advance - 0 0 0 0 0 - - - -
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 170.651 euro in 2020 which includes Inventories of 5.603 euro, Receivables of 147.797 euro and cash availability of 17.251 euro.
The company's Equity was valued at 113.398 euro, while total Liabilities amounted to 63.639 euro. Equity decreased by -4.074 euro, from 119.742 euro in 2019, to 113.398 in 2020.

Risk Reports Prices

Reviews - Propharma Plus S.r.l.

Comments - Propharma Plus S.r.l.

Comments can only be added from a RisCo client account. Login
See Comments

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.